Cargando…

Stathmin1 increases radioresistance by enhancing autophagy in non-small-cell lung cancer cells

Radioresistance has been demonstrated to be involved in the poor prognosis of patients with non-small-cell lung cancer (NSCLC). However, the underlying mechanism remains largely unclear. Investigation on special therapeutic targets associated with radioresistance shows promises for the enhancement o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xi, Ji, Jingfen, Yang, Yu, Zhang, Juan, Shen, Liangfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857807/ https://www.ncbi.nlm.nih.gov/pubmed/27199567 http://dx.doi.org/10.2147/OTT.S100468

Ejemplares similares

Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells
por: Kang, JiHoon, et al.
Publicado: (2016)

Radioresistance of Non-Small Cell Lung Cancers and Therapeutic Perspectives
por: Césaire, Mathieu, et al.
Publicado: (2022)

Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1
por: Zhang, Juan, et al.
Publicado: (2016)

Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer
por: Zhou, Ting, et al.
Publicado: (2023)

CRISPR/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cells
por: Shen, Lin, et al.
Publicado: (2021)

Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo
por: Tang, Yiting, et al.
Publicado: (2015)

RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer
por: Xie, Shi-Yang, et al.
Publicado: (2017)

REV1 Inhibition Enhances Radioresistance and Autophagy
por: Ikeh, Kanayo E., et al.
Publicado: (2021)

EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma
por: Xu, San, et al.
Publicado: (2021)

Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells
por: Pustovalova, Margarita, et al.
Publicado: (2023)

The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
por: Alhaddad, Lina, et al.
Publicado: (2022)

The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer
por: Zhu, Dao Qi, et al.
Publicado: (2022)

Quantitative Proteomic Analysis Identifies MAPK15 as a Potential Regulator of Radioresistance in Nasopharyngeal Carcinoma Cells
por: Li, Zhanzhan, et al.
Publicado: (2018)

NRF2-pathway mutations predict radioresistance in non-small cell lung cancer
por: Kinslow, Connor J., et al.
Publicado: (2022)

Identification of Key Genes and FUNCTIONAL Pathway in Radioresistance of Non-Small Cell Lung Cancer
por: Li, Shouying, et al.
Publicado: (2022)

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
por: Kuang, Xia-Ying, et al.
Publicado: (2015)

Stathmin 1 expression in plasma cell neoplasms
por: Machado-Neto, João Agostinho, et al.
Publicado: (2017)

Stromal cell‐derived small extracellular vesicles enhance radioresistance of prostate cancer cells via interleukin‐8‐induced autophagy
por: Wang, Xiumei, et al.
Publicado: (2023)

Stathmin 1 Induces Murine Hepatocyte Proliferation and Increased Liver Mass
por: Zhao, Enpeng, et al.
Publicado: (2019)

Caveolin-1 promotes radioresistance via IRGM-regulated autophagy in lung cancer
por: Chen, Xi, et al.
Publicado: (2021)

Enhancement of Chemosensitivity by Stathmin-1 Silencing in Gastric Cancer Cells In Situ and In Vivo
por: Meng, Zhi-jian, et al.
Publicado: (2016)

SOX2 Promotes Radioresistance in Non-small Cell Lung Cancer by Regulating Tumor Cells Dedifferentiation
por: Wang, Shennan, et al.
Publicado: (2023)

Suppresses of LIM kinase 2 promotes radiosensitivity in radioresistant non-small cell lung cancer cells
por: Tian, Chao, et al.
Publicado: (2023)

Evaluation of the role of mir-34b in modulation of radioresistance in non-small cell lung cancer
por: Silva, Joana B, et al.
Publicado: (2010)

FK228 sensitizes radioresistant small cell lung cancer cells to radiation
por: Li, Hong, et al.
Publicado: (2021)

Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response
por: Jiang, Weiwei, et al.
Publicado: (2019)

Stathmin guides personalized therapy in oral squamous cell carcinoma
por: Ju, Wu‐tong, et al.
Publicado: (2020)

Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells
por: Shen, Yuntian, et al.
Publicado: (2015)

P130cas-FAK interaction is essential for YAP-mediated radioresistance of non-small cell lung cancer
por: Li, Jingduo, et al.
Publicado: (2022)

Stathmin overexpression is associated with growth, invasion and metastasis of lung adenocarcinoma
por: Yurong, Lin, et al.
Publicado: (2016)

CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells
por: Li, Hang, et al.
Publicado: (2020)

Mesenchymal stem cells over-expressing cxcl12 enhance the radioresistance of the small intestine
por: Chang, Pengyu, et al.
Publicado: (2018)

Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non–small cell lung cancer cells
por: Yao, Yuan-Hu, et al.
Publicado: (2016)

ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition
por: Li, Yuexian, et al.
Publicado: (2021)

Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines
por: Gökyildirim, Mira Y., et al.
Publicado: (2018)

Stathmin dynamics modulate the activity of eribulin in breast cancer cells
por: Yoshie, Mikihiro, et al.
Publicado: (2021)

Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer
por: Zheng, Qin, et al.
Publicado: (2021)

Stathmin Is Dispensable for Tumor Onset in Mice
por: D’Andrea, Sara, et al.
Publicado: (2012)

Stathmin 1 in normal and malignant hematopoiesis
por: Machado-Neto, João Agostinho, et al.
Publicado: (2014)

Stathmin drives virus-induced metastasis
por: Whitehouse, Adrian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_32rlprncbfhk09icv8r2uqqhmk